Contents
pdf Download PDF pdf Download XML
98 Views
72 Downloads
Share this article
Research Article | Volume 7 Issue 3 (None, 2013) | Pages 82 - 83
Psoriasis treated successfully with ustekinumab in a cocaine-addicted patient
 ,
 ,
 ,
Under a Creative Commons license
Open Access
PMID : PMC3797014
Received
Jan. 21, 2012
Published
Sept. 30, 2013
Abstract

Background:Psoriasis is a chronic, immune-mediated inflammatory disease estimated approximately in 2% of the European population. Drug abuse is reported in 3-5% of the global population. Main observation:We present a 41-year-old, cocaine-addicted patient male with severe plaque-type psoriasis treated successfully with ustekinumab. The patient received ustekinumab at a dose of 45 mg subcutaneously at weeks 0, 4 and 16 and achieved PASI 75 at week 18.Conclusions:Although several drug-abusers experience psoriasis, literature is very poor regarding the outcome of systemic treatment in those patients. In our patient no adverse effects were seen during the administration period of ustekinumab and no interactions between cocaine and ustekinumab were noticed. Nevertheless, more individuals and further studies are needed to establish the efficacy and safety of ustekinumab in the treatment of psoriasis in drug-abusers.

Keywords
Recommended Articles
Original Article
Comparative Evaluation of Intralesional Corticosteroid Injection and Surgical Excision in Hypertrophic Scar Treatment
...
Published: 04/06/2022
Case Report
Concurrent Lepra Reactions; Type 1 and Type 2 in a young male patient with borderline leprosy: Clinical and Histopathological correlation
...
Published: 02/09/2025
Research Article
Efficacy of supra bioavailable itraconazole and conventional itraconazole at different dosing regimens in glabrous tinea infection
Published: 02/02/2024
Research Article
A Filipino male with encephalocraniocutaneous lipomatosis (Haberland’s syndrome)
Published: 30/06/2013
© Copyright Spejalisci Dermatolodzy